共 50 条
- [41] Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell helpIMMUNOLOGY, 2011, 132 (04) : 549 - 558Ontiveros, FernandoWilson, Elizabeth B.Livingstone, Alexandra M.
- [42] Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cellsJOURNAL OF IMMUNOLOGY, 1998, 160 (09): : 4500 - 4507Bot, ACasares, SBot, Svon Boehmer, HBona, C
- [43] Self-Tolerance Checkpoints in CD4 T Cells Specific for a Peptide Derived from the B Cell Antigen ReceptorJOURNAL OF IMMUNOLOGY, 2011, 187 (01): : 82 - 91Detanico, ThiagoHeiser, Ryan A.Aviszus, KatjaBonorino, CristinaWysocki, Lawrence J.
- [44] CD4+ T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transferJOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (04): : 481 - 492Tarbell, KVLee, MRanheim, EChao, CCSanna, MKim, SKDickie, PTeyton, LDavis, MMcDevitt, H
- [45] Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T Cells specifically inhibit Ewing sarcoma growth in vitro and in vivoONCOTARGET, 2016, 7 (28) : 43267 - 43280Blaeschke, FranziskaThiel, UweKirschner, AndreasThiede, MelanieRubio, Rebeca AlbaSchirmer, DavidKirchner, ThomasRichter, Guenther H. S.Mall, SabineKlar, RichardRiddell, StanleyBusch, Dirk H.Krackhardt, AngelaGrunewald, Thomas G. P.Burdach, Stefan
- [46] Human HLA-A*02:01/CHM1+allo-restricted T cell receptor-transgenic CD8+T cells specifically inhibit Ewing sarcoma growth in vitro and in vivoEUROPEAN JOURNAL OF CANCER, 2016, 69 : S51 - S51Thiel, U.Blaeschke, F.Richter, G.Burdach, S.
- [47] Analysis of the Conservation of T Cell Receptor Alpha and Beta Chain Variable Regions Gene in pp65 Peptide-Specific HLA-A~*0201-Restricted CD8~+ T CellsCellular & Molecular Immunology, 2009, 6 (02) : 105 - 110Wei Luo12School of Biosciences & Bioengineering
- [48] Retroviral transfer of an HLA class II restricted T cell receptor (TCR) to CD4+ or CD8+ T cells results in transfer of T cell specificity with all effector functions displayed by the TCR-receivingBLOOD, 2003, 102 (11) : 747A - 747Avan der Veken, LTFalkenburg, JHFWillemze, RHeemskerk, MHM
- [49] Analysis of the Conservation of T Cell Receptor Alpha and Beta Chain Variable Regions Gene in pp65 Peptide-Specific HLA-A*0201-Restricted CD8+ T CellsCellular & Molecular Immunology, 2009, 6 : 105 - 110Wei LuoLi MaQian WenMingqian ZhouXiaoning Wang
- [50] TCR-engineered neoantigen-specific CD4+ T cells mediate immunotherapy of a class II-negative murine squamous cell carcinomaJOURNAL OF IMMUNOLOGY, 2022, 208 (01):Brightman, Spencer E.Becker, AngelicaThota, RukmanNaradikian, Martin S.Griswold, RyanDolina, Joseph S.Schoenberger, Stephen P.